论文信息 - D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study - 字舞流文

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study

W. Ageno | P. Prandoni | N. Magrini | M. Moia | A. Tosetto | S. Testa | D. Poli | B. Cosmi | A. Falanga | O. Paoletti | E. Antonucci | C. Legnani | G. Palareti | F. Marongiu | F. Orlandini | R. Pesavento | R. Santoro | N. Erba | D. Imberti | A. D’Angelo | F. Lussana | M. Cattaneo | A. Tripodi | R. Cappelli | M. Donadini | A. Ghirarduzzi | V. Pengo | D. Prisco | P. Zonzin | R. Quintavalla | V. De Micheli | L. Crippa | M. Silingardi | E. Rancan | A. Pizzini | R. Benedetti | L. Angeloni | P. M. Ferrini | Elena Bertinato | Paolo Gualtiero Benilde Cristina Daniela Domenico Emilia Prandoni Palareti Cosmi Legnani Poli Prisco | M. R. Veropalumbo | M. Ugolotti | S. Luigi | Roberta Bortolotti | M. Vandelli | Noemi Piaggesi | Elena Rancan | P. Ferrini

[1] W. Ageno,et al. D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants , 2019, PloS one.

[2] M. Rodger,et al. Who should get long-term anticoagulant therapy for venous thromboembolism and with what? , 2018, Hematology. American Society of Hematology. Education Program.

[3] M. Rodger,et al. Who should get long-term anticoagulant therapy for venous thromboembolism and with what? , 2018, Blood advances.

[4] J. Eikelboom,et al. A Test in Context: D-Dimer. , 2017, Journal of the American College of Cardiology.

[5] W. Ageno,et al. External validation of the DASH prediction rule: a retrospective cohort study , 2017, Journal of thrombosis and haemostasis : JTH.

[6] T. Ortel,et al. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study , 2017, British Medical Journal.

[7] L. Mazzolai,et al. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use. , 2017, Thrombosis research.

[8] J. Douketis,et al. D-dimer testing to select patients with a first unprovoked venous thromboembolism who can stop anticoagulant therapy: a cohort study. , 2015, Annals of internal medicine.

[9] P. Prandoni,et al. D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study. , 2014, Blood.

[10] J. Gurwitz,et al. Venous thromboembolism in older adults: A community-based study. , 2014, The American journal of medicine.

[11] J. Douketis,et al. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH) , 2012, Journal of thrombosis and haemostasis : JTH.

[12] Paolo Prandoni,et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[13] B. Cosmi,et al. Age and gender specific cut-off values to improve the performance of d-dimer assays to predict the risk of venous thromboembolism recurrence , 2013, Internal and Emergency Medicine.

[14] J. Douketis,et al. Patient-Level Meta-analysis: Effect of Measurement Timing, Threshold, and Patient Age on Ability of d-Dimer Testing to Assess Recurrence Risk After Unprovoked Venous Thromboembolism , 2010, Annals of Internal Medicine.

[15] A. Iorio,et al. Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting , 2010, Journal of thrombosis and haemostasis : JTH.

[16] Georg Heinze,et al. Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model , 2010, Circulation.

[17] A. Tosetto,et al. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study. , 2010, Blood.

[18] Soheir S Adam,et al. D-dimer antigen: current concepts and future prospects. , 2009, Blood.

[19] J. Gurwitz,et al. Venous thromboembolism in the elderly , 2008, Thrombosis and Haemostasis.

[20] S. Kahn,et al. Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy , 2008, Canadian Medical Association Journal.

[21] C. Palmer,et al. Unprovoked recurrent venous thrombosis: prediction by D‐dimer and clinical risk factors , 2008, Journal of thrombosis and haemostasis : JTH.

[22] D. Strachan,et al. Diurnal, Seasonal, and Blood-Processing Patterns in Levels of Circulating Fibrinogen, Fibrin D-Dimer, C-Reactive Protein, Tissue Plasminogen Activator, and von Willebrand Factor in a 45-Year-Old Population , 2007, Circulation.

[23] A. Iorio,et al. D-dimer testing to determine the duration of anticoagulation therapy. , 2006, The New England journal of medicine.

[24] T. Baglin,et al. High risk of recurrent venous thromboembolism in men , 2004, Journal of thrombosis and haemostasis : JTH.

[25] E. Minar,et al. The risk of recurrent venous thromboembolism in men and women. , 2004, The New England journal of medicine.

[26] F. Spencer,et al. Risk Factors for Venous Thromboembolism , 2003, Circulation.

[27] J. Heit,et al. Risk factors for venous thromboembolism. , 2003, Clinics in chest medicine.

[28] H. Bounameaux,et al. Effects of age on the performance of common diagnostic tests for pulmonary embolism. , 2000, The American journal of medicine.